{"hands_on_practices": [{"introduction": "Failing to account for underlying differences between treated and untreated groups can lead to conclusions that are not just wrong, but the opposite of the truth. This exercise demonstrates how a crude, overall analysis can be dangerously misleading due to confounding, a phenomenon known as Simpson's paradox [@problem_id:4973496]. By calculating the marginal risk difference, you will see firsthand how an apparently harmful treatment can be beneficial once the analysis is properly stratified by a key factor.", "problem": "Consider an observational cohort study of hospitalized adults with community-acquired pneumonia evaluating the effect of an early broad-spectrum antibiotic ($T=1$) versus delayed or narrow-spectrum management ($T=0$) on a binary outcome of clinical recovery by day $30$ ($Y=1$ for recovery, $Y=0$ otherwise). Disease severity at admission is classified into two strata based on a validated severity index: stratum $\\mathcal{S}_{0}$ (milder presentation) and stratum $\\mathcal{S}_{1}$ (severe presentation). Severity is a potential confounder of the treatment-outcome relationship because it influences both treatment choice and prognosis.\n\nYou are given the following counts:\n\n- In stratum $\\mathcal{S}_{0}$: among the treated ($T=1$), $42$ of $50$ recovered; among the untreated ($T=0$), $320$ of $400$ recovered.\n- In stratum $\\mathcal{S}_{1}$: among the treated ($T=1$), $150$ of $600$ recovered; among the untreated ($T=0$), $18$ of $80$ recovered.\n\nUsing only fundamental probability definitions and without introducing untested modeling assumptions, compute the overall marginal risk difference, defined as\n$$ RD_{\\text{marginal}} \\equiv \\Pr(Y=1 \\mid T=1) - \\Pr(Y=1 \\mid T=0), $$\nwhen severity strata are ignored (that is, collapsed across $\\mathcal{S}_{0}$ and $\\mathcal{S}_{1}$). Express your answer as a decimal and round your final result to four significant figures.", "solution": "The problem statement has been critically validated and is deemed valid. It is scientifically grounded, well-posed, and objective. It presents a standard epidemiological task based on provided count data, allowing for a unique and meaningful solution. All necessary information is provided, and there are no contradictions or ambiguities.\n\nThe objective is to compute the overall marginal risk difference, $RD_{\\text{marginal}}$, which quantifies the difference in the probability of recovery between the treated and untreated groups when the confounding variable, disease severity, is ignored. The definition is given as:\n$$\nRD_{\\text{marginal}} \\equiv \\Pr(Y=1 \\mid T=1) - \\Pr(Y=1 \\mid T=0)\n$$\nHere, $Y=1$ denotes recovery, $T=1$ denotes receiving the early broad-spectrum antibiotic treatment, and $T=0$ denotes the alternative management. The probabilities are estimated from the provided sample counts.\n\nThe problem requires us to collapse the data across the two severity strata, $\\mathcal{S}_{0}$ (milder) and $\\mathcal{S}_{1}$ (severe). We first aggregate the counts for the treated population ($T=1$) and the untreated population ($T=0$) across both strata.\n\nLet $N_{T=t, S=s}$ be the number of individuals and $C_{T=t, S=s}$ be the count of recovered individuals, for treatment status $t \\in \\{0, 1\\}$ and stratum $s \\in \\{0, 1\\}$.\n\nThe given data are:\nFor stratum $\\mathcal{S}_{0}$:\n- Treated ($T=1$): $C_{T=1, S=0} = 42$, $N_{T=1, S=0} = 50$.\n- Untreated ($T=0$): $C_{T=0, S=0} = 320$, $N_{T=0, S=0} = 400$.\n\nFor stratum $\\mathcal{S}_{1}$:\n- Treated ($T=1$): $C_{T=1, S=1} = 150$, $N_{T=1, S=1} = 600$.\n- Untreated ($T=0$): $C_{T=0, S=1} = 18$, $N_{T=0, S=1} = 80$.\n\nTo calculate the marginal probabilities, we first find the total counts for the entire study population, collapsed across strata.\n\nTotal number of recovered individuals in the treated group ($T=1$):\n$$\nC_{T=1} = C_{T=1, S=0} + C_{T=1, S=1} = 42 + 150 = 192\n$$\nTotal number of individuals in the treated group ($T=1$):\n$$\nN_{T=1} = N_{T=1, S=0} + N_{T=1, S=1} = 50 + 600 = 650\n$$\n\nTotal number of recovered individuals in the untreated group ($T=0$):\n$$\nC_{T=0} = C_{T=0, S=0} + C_{T=0, S=1} = 320 + 18 = 338\n$$\nTotal number of individuals in the untreated group ($T=0$):\n$$\nN_{T=0} = N_{T=0, S=0} + N_{T=0, S=1} = 400 + 80 = 480\n$$\n\nNow, we estimate the marginal probabilities (risks) of recovery for each treatment group using these aggregated counts.\n\nThe probability of recovery given treatment ($T=1$) is estimated as:\n$$\n\\Pr(Y=1 \\mid T=1) \\approx \\frac{C_{T=1}}{N_{T=1}} = \\frac{192}{650}\n$$\n\nThe probability of recovery given no treatment ($T=0$) is estimated as:\n$$\n\\Pr(Y=1 \\mid T=0) \\approx \\frac{C_{T=0}}{N_{T=0}} = \\frac{338}{480}\n$$\n\nFinally, we compute the marginal risk difference by subtracting the risk in the untreated group from the risk in the treated group:\n$$\nRD_{\\text{marginal}} \\approx \\frac{192}{650} - \\frac{338}{480}\n$$\nWe convert these fractions to their decimal representations for calculation:\n$$\n\\frac{192}{650} \\approx 0.2953846...\n$$\n$$\n\\frac{338}{480} = \\frac{169}{240} \\approx 0.7041666...\n$$\nThe risk difference is therefore:\n$$\nRD_{\\text{marginal}} \\approx 0.2953846 - 0.7041666 = -0.408782...\n$$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $4$, $0$, $8$, and $7$. The fifth significant figure is $8$, which is $\\ge 5$, so we round up the fourth significant figure.\n$$\nRD_{\\text{marginal}} \\approx -0.4088\n$$\nThis negative value indicates that in this crude, unadjusted analysis, the early broad-spectrum antibiotic treatment is associated with a substantially lower probability of recovery compared to the alternative management. This counterintuitive result is a classic example of confounding by indication (a form of Simpson's paradox), where the sickest patients are preferentially given the treatment being studied, making the treatment appear harmful when in fact it may be beneficial or neutral.", "answer": "$$\n\\boxed{-0.4088}\n$$", "id": "4973496"}, {"introduction": "After seeing the power of stratification, a common impulse is to adjust for any variable that seems related to the outcome. This practice problem reveals the peril of that approach by exploring collider-stratification bias, where adjusting for a post-treatment variable can introduce bias instead of removing it [@problem_id:4973424]. Using a causal diagram and a concrete numerical example, you will learn to identify when conditioning creates spurious associations, a critical skill for interpreting results from both observational studies and clinical trials.", "problem": "A clinical trial investigates the effect of an antihypertensive treatment on subsequent risk of stroke. Let the binary exposure be $A \\in \\{0,1\\}$ (where $A=1$ denotes treatment), the binary outcome be $Y \\in \\{0,1\\}$ (where $Y=1$ denotes stroke within $1$ year), and a biomarker measured at $3$ months post-randomization be $M \\in \\{0,1\\}$ (where $M=1$ denotes normalized blood pressure at $3$ months). Suppose randomization ensures $A$ is independent of all pretreatment common causes of $Y$ so that, marginally, comparing $Y$ across $A$ identifies a causal effect. Consider an unmeasured patient factor $U$ (for example, genetic variation affecting vascular reactivity) such that $U$ affects both $M$ and $Y$, but $U$ does not affect $A$ due to randomization. The data-generating process is consistent with a Directed Acyclic Graph (DAG) having arrows $A \\to M \\to Y$ and $U \\to M$, $U \\to Y$, and no arrow from $U$ to $A$. A collaborator proposes to stratify on the biomarker $M$ to address “residual confounding.”\n\nTo make concrete the phenomenon under discussion, suppose the following conditional probabilities are approximately observed in a very large trial:\n- $P(M=1 \\mid A=1) \\approx 0.85$, $P(M=1 \\mid A=0) \\approx 0.15$,\n- $P(Y=1 \\mid A=1, M=1) \\approx 0.18$, $P(Y=1 \\mid A=0, M=1) \\approx 0.10$,\n- $P(Y=1 \\mid A=1, M=0) \\approx 0.40$, $P(Y=1 \\mid A=0, M=0) \\approx 0.30$.\n\nFrom these, the marginal risks satisfy $P(Y=1 \\mid A=1) \\approx 0.85 \\cdot 0.18 + 0.15 \\cdot 0.40 = 0.213$ and $P(Y=1 \\mid A=0) \\approx 0.15 \\cdot 0.10 + 0.85 \\cdot 0.30 = 0.270$, so the marginal association suggests benefit of treatment ($0.213  0.270$), while within each stratum of $M$ the association appears harmful ($0.18 > 0.10$ and $0.40 > 0.30$). You are to evaluate, from first principles, the impact of stratifying on a post-treatment variable on the occurrence of Simpson’s paradox and to justify whether such stratification addresses confounding or introduces bias.\n\nWhich statement best explains these findings and correctly characterizes the impact of stratifying on $M$?\n\nA. Stratifying on the post-treatment $M$ can induce a reversal of the exposure–outcome association (an instance of Simpson’s paradox) by opening the noncausal path $A \\to M \\leftarrow U \\to Y$; this is selection bias due to conditioning on a collider and biases the total effect even under randomization, so it does not resolve confounding.\n\nB. Because $A$ is randomized, stratifying on any variable including $M$ cannot change the direction of the association between $A$ and $Y$; any reversal must reflect model misspecification rather than bias.\n\nC. Since $U$ affects both $M$ and $Y$, stratifying on $M$ blocks the backdoor path through $U$ and therefore removes confounding, ensuring the within-stratum comparisons identify the causal effect.\n\nD. Matching treated and untreated patients on $M$ (instead of stratifying) avoids selection bias induced by conditioning on post-treatment variables and thus resolves the reversal.\n\nE. The reversal within $M$ strata indicates that stratification on $M$ consistently identifies the controlled direct effect of $A$ on $Y$ not mediated by $M$, regardless of the presence of $U$.", "solution": "The user wants me to validate the problem statement and, if valid, provide a detailed solution based on first principles, evaluating each option.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\n*   **Variables:**\n    *   Exposure: Binary, $A \\in \\{0, 1\\}$, with $A=1$ for treatment.\n    *   Outcome: Binary, $Y \\in \\{0, 1\\}$, with $Y=1$ for stroke within $1$ year.\n    *   Biomarker: Binary, $M \\in \\{0, 1\\}$, a post-treatment variable measured at $3$ months, with $M=1$ for normalized blood pressure.\n    *   Unmeasured Factor: $U$, a patient factor.\n*   **Causal Structure (from problem description and DAG):**\n    *   Randomization implies $A$ is independent of pretreatment common causes. Specifically, there is no arrow from $U$ to $A$, which means $A \\perp U$.\n    *   The causal pathways are specified as consistent with a Directed Acyclic Graph (DAG) with arrows $A \\to M$, $M \\to Y$, $U \\to M$, and $U \\to Y$.\n*   **Observational Data (from a very large trial):**\n    *   $P(M=1 \\mid A=1) \\approx 0.85$\n    *   $P(M=1 \\mid A=0) \\approx 0.15$\n    *   $P(Y=1 \\mid A=1, M=1) \\approx 0.18$\n    *   $P(Y=1 \\mid A=0, M=1) \\approx 0.10$\n    *   $P(Y=1 \\mid A=1, M=0) \\approx 0.40$\n    *   $P(Y=1 \\mid A=0, M=0) \\approx 0.30$\n*   **Derived Marginal Risks:**\n    *   $P(Y=1 \\mid A=1) \\approx 0.213$\n    *   $P(Y=1 \\mid A=0) \\approx 0.270$\n*   **Key Phenomenon:**\n    *   The marginal association suggests benefit (risk is lower with treatment: $0.213  0.270$).\n    *   The association within each stratum of $M$ suggests harm (risk is higher with treatment: $0.18  0.10$ in stratum $M=1$, and $0.40  0.30$ in stratum $M=0$). This reversal is an instance of Simpson's paradox.\n*   **Question:** Explain the findings and characterize the impact of stratifying on the post-treatment variable $M$.\n\n**Step 2: Validate Using Extracted Givens**\n\n1.  **Scientifically Grounded:** The problem describes a classic scenario in epidemiology and causal inference. The use of DAGs, the concepts of randomization, confounding, mediation, and collider-stratification bias are all standard and well-established principles. The example illustrates a known paradox (Simpson's paradox) in a plausible clinical trial context. The problem is scientifically sound.\n2.  **Well-Posed:** The problem is well-posed. It provides a clear causal structure, data consistent with that structure, and asks for an explanation based on established theory. A unique explanation derived from causal inference principles exists.\n3.  **Objective:** The problem is stated in objective, formal language. The numerical values are given as approximations from a large trial, which is a standard way to frame such problems.\n4.  **Complete and Consistent:** All necessary information (the DAG structure, randomization, and data) is provided. The provided marginal risk calculations are confirmed to be correct based on the law of total probability:\n    *   $P(Y=1 \\mid A=1) = P(Y=1 \\mid M=1, A=1)P(M=1 \\mid A=1) + P(Y=1 \\mid M=0, A=1)P(M=0 \\mid A=1) = (0.18)(0.85) + (0.40)(1-0.85) = 0.153 + 0.06 = 0.213$.\n    *   $P(Y=1 \\mid A=0) = P(Y=1 \\mid M=1, A=0)P(M=1 \\mid A=0) + P(Y=1 \\mid M=0, A=0)P(M=0 \\mid A=0) = (0.10)(0.15) + (0.30)(1-0.15) = 0.015 + 0.255 = 0.270$.\n    The setup is internally consistent.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is valid. It is a well-constructed, classic problem in causal inference. I will proceed to the solution.\n\n### Derivation of Solution\n\nThe core of this problem lies in understanding causal inference from a Directed Acyclic Graph (DAG). The specified DAG has the following structure:\n1.  A directed path from exposure to outcome, mediated by $M$: $A \\to M \\to Y$. This represents the causal effect of the treatment on stroke that operates by changing blood pressure.\n2.  An unmeasured common cause $U$ of the mediator $M$ and the outcome $Y$: $M \\leftarrow U \\to Y$. This means $U$ confounds the relationship between $M$ and $Y$.\n3.  Randomization ensures the exposure $A$ is not caused by $U$, so there is no arrow $U \\to A$.\n\n**Total Causal Effect of A on Y**\nThe total causal effect of $A$ on $Y$ is the net result of all causal pathways from $A$ to $Y$. In this DAG, the only causal pathway is $A \\to M \\to Y$. To obtain an unbiased estimate of this total effect, we must block all non-causal \"backdoor\" paths between $A$ and $Y$. A backdoor path is a path that enters $A$ through its back (i.e., starts with an arrow pointing to $A$). Due to randomization ($A \\perp U$), there are no common causes of $A$ and $Y$, and hence no open backdoor paths. The marginal association, comparing $P(Y=1 \\mid A=1)$ to $P(Y=1 \\mid A=0)$, is therefore an unbiased estimate of the total causal effect of $A$ on $Y$.\nThe data show this effect to be a risk reduction: $P(Y=1 \\mid A=1) - P(Y=1 \\mid A=0) = 0.213 - 0.270 = -0.057$. The treatment is, overall, beneficial.\n\n**Impact of Stratifying on M**\nThe collaborator's proposal is to stratify the analysis by $M$. This means examining the association between $A$ and $Y$ *within* levels of $M$. To understand the consequence of this, we must use the rules of d-separation on the DAG.\nConsider the path $A \\to M \\leftarrow U \\to Y$. The variable $M$ on this path is a **collider**, defined as a variable that receives arrows from two other variables on the path.\nThe rules of d-separation state:\n1.  A path is blocked by a non-collider that is conditioned on.\n2.  A path is blocked by a collider that is **not** conditioned on (and no descendant of the collider is conditioned on).\n3.  A path is opened by a collider that **is** conditioned on.\n\nIn the marginal (unstratified) analysis, we do not condition on $M$. Therefore, the collider $M$ blocks the non-causal path $A \\to M \\leftarrow U \\to Y$. The only open path is the causal one, $A \\to M \\to Y$.\n\nWhen we stratify by $M$, we are conditioning on it. This action **opens** the previously blocked non-causal path $A \\to M \\leftarrow U \\to Y$. The association between $A$ and $Y$ within strata of $M$ is now a mixture of the true causal effect part (if any part of it remains) and a spurious, non-causal association flowing along this newly opened path. This induced non-causal association is a form of **selection bias**, often called **collider-stratification bias**.\n\nThe observed Simpson's paradox is a direct result of this bias. Within each stratum of $M$, a spurious association between $A$ and $Y$ is created, which in this case is strong enough to overwhelm and reverse the direction of the true effect. For instance, in the $M=1$ stratum (normalized BP), patients with $A=0$ are those who achieved normal BP without treatment; they are likely to be healthier in terms of unmeasured factors like $U$. Patients with $A=1$ who are in this stratum include those who needed the treatment to normalize their BP, a group likely enriched with individuals with unfavorable $U$ status. Since $U$ also directly increases the risk of $Y$, this creates a spurious association making the treatment ($A=1$) appear harmful compared to no treatment ($A=0$) within the $M=1$ stratum. A similar logic applies to the $M=0$ stratum.\n\nStratifying on $M$ does not \"address confounding.\" Randomization already dealt with confounding of the $A-Y$ relationship. Instead, this stratification *introduces* bias.\n\n### Evaluation of Options\n\n**A. Stratifying on the post-treatment $M$ can induce a reversal of the exposure–outcome association (an instance of Simpson’s paradox) by opening the noncausal path $A \\to M \\leftarrow U \\to Y$; this is selection bias due to conditioning on a collider and biases the total effect even under randomization, so it does not resolve confounding.**\n\n*   **Analysis:** This statement is perfectly aligned with the derivation from first principles. It correctly identifies the phenomenon as Simpson's paradox, attributes it to conditioning on the post-treatment variable $M$, correctly identifies $M$ as a collider on the path $A \\to M \\leftarrow U \\to Y$, names the resulting bias as selection bias (collider bias), and correctly concludes that this analytic choice biases the effect estimate and does not resolve any confounding.\n*   **Verdict:** **Correct**.\n\n**B. Because $A$ is randomized, stratifying on any variable including $M$ cannot change the direction of the association between $A$ and $Y$; any reversal must reflect model misspecification rather than bias.**\n\n*   **Analysis:** This statement is false. Randomization ensures the marginal association is unbiased for the total effect but provides no such protection for conditional associations, particularly when conditioning on a post-treatment variable. Conditioning on a collider is a well-known mechanism for inducing bias, and it can readily change or reverse the direction of an association. The reversal is a real structural feature of the data, not a \"model misspecification\".\n*   **Verdict:** **Incorrect**.\n\n**C. Since $U$ affects both $M$ and $Y$, stratifying on $M$ blocks the backdoor path through $U$ and therefore removes confounding, ensuring the within-stratum comparisons identify the causal effect.**\n\n*   **Analysis:** This statement makes two fundamental errors. First, there is no \"backdoor path through $U$\" from $A$ to $Y$. The path involving $U$ is $A \\to M \\leftarrow U \\to Y$, which is not a backdoor path because the first arrow points away from $A$. Second, stratifying on the collider $M$ does not block this path; it *opens* it. The logic is completely reversed.\n*   **Verdict:** **Incorrect**.\n\n**D. Matching treated and untreated patients on $M$ (instead of stratifying) avoids selection bias induced by conditioning on post-treatment variables and thus resolves the reversal.**\n\n*   **Analysis:** Matching on a variable is a method of conditioning on that variable. Matching on $M$ aims to create groups of treated and untreated subjects with the same distribution of $M$. It is functionally equivalent to stratification in its effect on bias. Therefore, matching on the collider $M$ will induce the same selection bias as stratification and will not resolve the paradox.\n*   **Verdict:** **Incorrect**.\n\n**E. The reversal within $M$ strata indicates that stratification on $M$ consistently identifies the controlled direct effect of $A$ on $Y$ not mediated by $M$, regardless of the presence of $U$.**\n\n*   **Analysis:** The \"controlled direct effect\" (CDE) is the effect of $A$ on $Y$ while holding $M$ fixed at some level. The conditional association $P(Y \\mid A, M)$ identifies the CDE only if there are no unmeasured common causes of the mediator ($M$) and outcome ($Y$). In this problem, the variable $U$ is precisely such an unmeasured common cause ($M \\leftarrow U \\to Y$). The presence of $U$ confounds the mediator-outcome relationship, and therefore the simple stratified association is a biased estimator of the CDE. The clause \"regardless of the presence of $U$\" is explicitly false.\n*   **Verdict:** **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "4973424"}, {"introduction": "Real-world confounding control is a balancing act; perfect adjustment is rarely possible, forcing us to navigate trade-offs between accuracy and precision. This final exercise tackles the classic bias-variance trade-off inherent in caliper matching [@problem_id:4973457]. You will derive the optimal caliper width that minimizes total estimation error, demonstrating how a principled approach can balance the risk of bias from imperfect matches against the risk of high variance from a small sample size.", "problem": "A clinical cohort study uses one-to-one caliper matching on a single continuous confounder $X$ to estimate the average treatment effect from observational data. For each treated unit, a control is eligible if its covariate value lies within a symmetric caliper of half-width $w$, that is, if $|X_{\\text{control}} - X_{\\text{treated}}| \\leq w$. If no eligible control is available, the treated unit is discarded. Matching is performed with replacement across treated units. The outcome model is\n$$\nY \\;=\\; \\tau\\,T \\;+\\; \\beta\\,X \\;+\\; \\varepsilon,\n$$\nwhere $T \\in \\{0,1\\}$ denotes treatment, $\\tau$ is the causal estimand of interest, $\\beta \\neq 0$ is the confounder slope, and $\\varepsilon$ is mean-zero noise with $\\operatorname{Var}(\\varepsilon) = \\sigma^{2}$, independent of $X$ and $T$ conditional on $X$.\n\nAssume the following simple local model for the supply of eligible controls and the residual covariate imbalance induced by calipers:\n\n1. Controls along the $X$-axis can be modeled as a homogeneous Poisson process with linear intensity $\\rho  0$ per unit length. For a treated unit located at $X_{\\text{treated}} = x$, the number of available controls in the interval $[x-w,\\,x+w]$ is Poisson with mean $2\\rho w$, and the event of having at least one eligible control is independent across treated units.\n\n2. For small $w$, the conditional expectation of the matched covariate difference $D := X_{\\text{treated}} - X_{\\text{control}}$ among successfully matched pairs satisfies a first-order expansion\n$$\n\\mathbb{E}\\!\\left[D \\,\\middle|\\, |D| \\leq w,\\,\\text{matched}\\right] \\;=\\; \\gamma\\,w \\;+\\; o(w),\n$$\nfor some constant $\\gamma \\in \\mathbb{R}$ determined by local treated-control covariate imbalance and matching mechanics. You may assume $\\gamma  0$ and treat it as known. Further, the conditional variance contribution from $D$ at the optimum is negligible compared to the outcome noise, so that the per-pair variance of the difference $Y_{\\text{treated}} - Y_{\\text{control}}$ can be approximated by $2\\sigma^{2}$.\n\nLet the estimator $\\widehat{\\tau}(w)$ be the average of $Y_{\\text{treated}} - Y_{\\text{control}}$ over all matched pairs under caliper width $w$. Let $n$ denote the number of treated units. Work in the small-caliper approximation where the match probability per treated unit satisfies $p(w) \\approx 2\\rho w$, so the expected number of matched pairs is $m(w) \\approx n\\,p(w) \\approx 2\\rho n\\,w$.\n\nStarting only from the definitions of bias, variance, and mean squared error, together with the Poisson process and linear outcome model assumptions stated above, derive the leading-order mean squared error as a function of $w$, and then obtain the caliper width $w^{\\star}$ that minimizes this mean squared error in closed form. Express your final answer as a single analytic expression in terms of $\\beta$, $\\gamma$, $\\sigma^{2}$, $\\rho$, and $n$. No numerical evaluation is required and no rounding should be performed. Your final answer must be a single expression.", "solution": "The problem asks for the optimal caliper width $w^{\\star}$ that minimizes the mean squared error (MSE) of the treatment effect estimator $\\widehat{\\tau}(w)$. The MSE is the sum of the squared bias and the variance of the estimator. We will derive expressions for the bias and variance as functions of the caliper half-width $w$, combine them to form the MSE, and then minimize this expression with respect to $w$.\n\nLet $M$ be the number of matched pairs obtained from the initial $n$ treated units. The estimator for the average treatment effect $\\tau$ is the average difference in outcomes between treated and control units over the $M$ matched pairs:\n$$ \\widehat{\\tau}(w) = \\frac{1}{M} \\sum_{i=1}^{M} (Y_{i,1} - Y_{i,0}) $$\nwhere $Y_{i,1}$ and $Y_{i,0}$ are the outcomes for the treated and control unit in pair $i$, respectively.\n\nThe outcome model is given as $Y = \\tau\\,T + \\beta\\,X + \\varepsilon$, where $T=1$ for treated and $T=0$ for control. For a single matched pair $(i)$, the outcomes are:\n$$ Y_{i,1} = \\tau \\cdot 1 + \\beta X_{i,1} + \\varepsilon_{i,1} $$\n$$ Y_{i,0} = \\tau \\cdot 0 + \\beta X_{i,0} + \\varepsilon_{i,0} $$\nThe difference in outcomes for this pair is:\n$$ Y_{i,1} - Y_{i,0} = (\\tau + \\beta X_{i,1} + \\varepsilon_{i,1}) - (\\beta X_{i,0} + \\varepsilon_{i,0}) = \\tau + \\beta (X_{i,1} - X_{i,0}) + (\\varepsilon_{i,1} - \\varepsilon_{i,0}) $$\nLet $D_i = X_{i,1} - X_{i,0}$ be the covariate difference for pair $i$. The estimator can be written as:\n$$ \\widehat{\\tau}(w) = \\frac{1}{M} \\sum_{i=1}^{M} \\left( \\tau + \\beta D_i + (\\varepsilon_{i,1} - \\varepsilon_{i,0}) \\right) = \\tau + \\beta \\left(\\frac{1}{M} \\sum_{i=1}^{M} D_i\\right) + \\frac{1}{M} \\sum_{i=1}^{M} (\\varepsilon_{i,1} - \\varepsilon_{i,0}) $$\n\nFirst, we calculate the bias of the estimator, $\\text{Bias}[\\widehat{\\tau}(w)] = \\mathbb{E}[\\widehat{\\tau}(w)] - \\tau$. The expectation is taken over all matched pairs.\n$$ \\mathbb{E}[\\widehat{\\tau}(w)] = \\mathbb{E}\\left[\\tau + \\beta \\left(\\frac{1}{M} \\sum_{i=1}^{M} D_i\\right) + \\frac{1}{M} \\sum_{i=1}^{M} (\\varepsilon_{i,1} - \\varepsilon_{i,0})\\right] $$\nGiven that the noise term $\\varepsilon$ has mean zero, $\\mathbb{E}[\\varepsilon_{i,1} - \\varepsilon_{i,0}]=0$. Since matching is done with replacement, the pairs are independent and identically distributed. Thus, the expectation of the average difference $\\bar{D}$ is the expectation of a single difference $D$ for a successfully matched pair.\n$$ \\mathbb{E}[\\widehat{\\tau}(w)] = \\tau + \\beta \\, \\mathbb{E}[D_i \\,|\\, \\text{matched}] $$\nThe problem provides the conditional expectation of the matched covariate difference for small $w$:\n$$ \\mathbb{E}[D \\,|\\, |D| \\leq w, \\text{matched}] = \\gamma w + o(w) $$\nUsing the leading-order term, the bias is:\n$$ \\text{Bias}[\\widehat{\\tau}(w)] = (\\tau + \\beta \\gamma w) - \\tau = \\beta \\gamma w $$\nThe squared bias is therefore:\n$$ (\\text{Bias}[\\widehat{\\tau}(w)])^2 = (\\beta \\gamma w)^2 = \\beta^2 \\gamma^2 w^2 $$\n\nNext, we calculate the variance of the estimator, $\\text{Var}[\\widehat{\\tau}(w)]$. We use the approximation that the random number of matched pairs, $M$, can be replaced by its expectation, $m(w)$. The problem provides this as $m(w) \\approx 2\\rho n w$.\n$$ \\text{Var}[\\widehat{\\tau}(w)] = \\text{Var}\\left(\\frac{1}{M} \\sum_{i=1}^{M} (Y_{i,1} - Y_{i,0})\\right) \\approx \\text{Var}\\left(\\frac{1}{m(w)} \\sum_{i=1}^{m(w)} (Y_{i,1} - Y_{i,0})\\right) $$\nSince the pairs are i.i.d., the variance of the mean is the variance of a single observation divided by the sample size:\n$$ \\text{Var}[\\widehat{\\tau}(w)] \\approx \\frac{1}{m(w)} \\text{Var}(Y_1 - Y_0) $$\nThe problem states that the per-pair variance can be approximated as $\\text{Var}(Y_1 - Y_0) \\approx 2\\sigma^2$. Substituting this and the expression for $m(w)$:\n$$ \\text{Var}[\\widehat{\\tau}(w)] \\approx \\frac{2\\sigma^2}{m(w)} = \\frac{2\\sigma^2}{2\\rho n w} = \\frac{\\sigma^2}{\\rho n w} $$\n\nNow we can write the mean squared error, $\\text{MSE}(w)$, as the sum of the squared bias and the variance:\n$$ \\text{MSE}(w) = (\\text{Bias}[\\widehat{\\tau}(w)])^2 + \\text{Var}[\\widehat{\\tau}(w)] $$\n$$ \\text{MSE}(w) \\approx \\beta^2 \\gamma^2 w^2 + \\frac{\\sigma^2}{\\rho n w} $$\nTo find the optimal caliper width $w^{\\star}$ that minimizes the MSE, we differentiate $\\text{MSE}(w)$ with respect to $w$ and set the result to zero.\n$$ \\frac{d}{dw} \\text{MSE}(w) = \\frac{d}{dw} \\left(\\beta^2 \\gamma^2 w^2 + \\frac{\\sigma^2}{\\rho n} w^{-1}\\right) $$\n$$ \\frac{d}{dw} \\text{MSE}(w) = 2 \\beta^2 \\gamma^2 w - \\frac{\\sigma^2}{\\rho n} w^{-2} $$\nSetting the derivative to zero:\n$$ 2 \\beta^2 \\gamma^2 w^{\\star} - \\frac{\\sigma^2}{\\rho n (w^{\\star})^2} = 0 $$\n$$ 2 \\beta^2 \\gamma^2 w^{\\star} = \\frac{\\sigma^2}{\\rho n (w^{\\star})^2} $$\n$$ (w^{\\star})^3 = \\frac{\\sigma^2}{2 \\rho n \\beta^2 \\gamma^2} $$\nSolving for $w^{\\star}$ by taking the cube root gives the optimal caliper width:\n$$ w^{\\star} = \\left(\\frac{\\sigma^2}{2 \\rho n \\beta^2 \\gamma^2}\\right)^{1/3} $$\nTo confirm this is a minimum, we examine the second derivative:\n$$ \\frac{d^2}{dw^2} \\text{MSE}(w) = 2 \\beta^2 \\gamma^2 + \\frac{2\\sigma^2}{\\rho n} w^{-3} $$\nSince $\\rho  0$, $n0$, $\\sigma^20$, and $w0$, both terms are positive. The second derivative is positive, which confirms that $w^{\\star}$ is a local minimum. As this is the only critical point for $w0$, it is the global minimum.", "answer": "$$\\boxed{\\left(\\frac{\\sigma^2}{2 n \\rho \\beta^2 \\gamma^2}\\right)^{1/3}}$$", "id": "4973457"}]}